Wolf-Rüdiger Schäbitz Selected Research

Granulocyte Colony-Stimulating Factor Receptors (G-CSF Receptor)

4/2007	New targets for established proteins: exploring G-CSF for the treatment of stroke.
1/2007	Granulocyte-colony stimulating factor (G-CSF) and G-CSF receptor expression in human ischemic stroke.
5/2006	Granulocyte-colony stimulating factor is neuroprotective in a model of Parkinson's disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Wolf-Rüdiger Schäbitz Research Topics

Disease

52	Stroke (Strokes) 04/2022 - 02/2002
22	Infarction (Infarctions) 01/2022 - 02/2002
17	Ischemia 01/2016 - 08/2005
13	Brain Ischemia (Cerebral Ischemia) 03/2016 - 10/2002
10	Ischemic Stroke 01/2017 - 10/2002
7	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 01/2017 - 02/2002
3	Encephalitis (Encephalitis, Rasmussen) 01/2022 - 12/2007
3	Hemorrhage 01/2020 - 04/2009
3	Gliosis 03/2016 - 01/2011
3	Neurodegenerative Diseases (Neurodegenerative Disease) 05/2012 - 08/2005
3	Body Weight (Weight, Body) 01/2011 - 05/2006
3	Hypothermia 11/2004 - 02/2002
2	Coma (Comas) 01/2022 - 05/2014
2	Thrombosis (Thrombus) 12/2021 - 08/2012
2	Parkinson Disease (Parkinson's Disease) 01/2021 - 05/2006
2	Embolic Stroke 01/2020 - 01/2020
2	Inflammation (Inflammations) 03/2016 - 09/2013
2	Brain Edema (Cerebral Edema) 08/2014 - 10/2002
2	Atrial Fibrillation 10/2013 - 04/2009
2	Chronic Renal Insufficiency 10/2013 - 02/2010
2	Atrophy 01/2012 - 12/2008
2	Myocardial Infarction 02/2010 - 10/2006
2	Neutropenia 10/2009 - 01/2008
2	Cerebral Infarction 11/2004 - 10/2002
1	Thrombocytopenia (Thrombopenia) 12/2021
1	Chemical and Drug Induced Liver Injury 01/2021
1	Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome) 01/2021
1	Acute Disseminated Encephalomyelitis (Postinfectious Encephalomyelitis) 01/2021
1	Blood Vessel Dissection 11/2020
1	Glioma (Gliomas) 07/2020
1	Embolism (Embolus) 01/2020
1	Hemianopsia (Bitemporal Hemianopsia) 01/2020
1	Brain Stem Infarctions (Weber Syndrome) 01/2018
1	Cerebral Small Vessel Diseases 07/2017
1	Epilepsy (Aura) 07/2017
1	Autoimmune Diseases of the Nervous System 11/2014
1	Creutzfeldt-Jakob Syndrome (Creutzfeldt-Jakob Disease) 11/2014
1	Hypertension (High Blood Pressure) 01/2014

Drug/Important Bio-Agent (IBA)

26	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 03/2016 - 08/2005
10	Pharmaceutical PreparationsIBA 07/2012 - 08/2005
6	Neuroprotective AgentsIBA 01/2020 - 09/2006
5	Proteins (Proteins, Gene)FDA Link 07/2020 - 04/2007
5	LigandsIBA 01/2016 - 08/2005
4	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 07/2017 - 06/2008
3	N-Methylaspartate (NMDA)IBA 01/2016 - 09/2006
3	AMPA Receptors (AMPA Receptor)IBA 01/2016 - 09/2006
3	CytokinesIBA 01/2011 - 09/2009
3	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2009 - 07/2007
3	Granulocyte Colony-Stimulating Factor Receptors (G-CSF Receptor)IBA 04/2007 - 05/2006
2	AnticoagulantsIBA 11/2020 - 10/2013
2	AntibodiesIBA 07/2020 - 11/2014
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2020 - 01/2020
2	Thrombin FDA Link 01/2020 - 01/2020
2	Dabigatran FDA Link 01/2020 - 01/2020
2	alpha- Amino- 3- hydroxy- 5- methyl- 4- isoxazolepropionic Acid (AMPA)IBA 01/2016 - 09/2006
2	Dizocilpine Maleate (Dizocilpine)IBA 01/2016 - 09/2006
2	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 12/2014 - 09/2006
2	Interleukin-6 (Interleukin 6)IBA 09/2013 - 01/2011
2	Chemotactic FactorsIBA 09/2013 - 01/2011
2	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 09/2013 - 01/2011
2	Tissue Plasminogen Activator (Alteplase)FDA Link 10/2011 - 04/2006
2	ChemokinesIBA 01/2011 - 11/2010
2	Erythropoietin FDA Link 01/2011 - 09/2009
2	Antihypertensive Agents (Antihypertensives)IBA 01/2010 - 01/2009
2	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2008 - 10/2007
2	SilverIBA 11/2004 - 10/2002
1	COVID-19 VaccinesIBA 01/2022
1	Intravenous Immunoglobulins (IVIG)FDA Link 12/2021
1	AntithrombinsIBA 12/2021
1	VaccinesIBA 12/2021
1	Dextroamphetamine (Dexedrine)FDA LinkGeneric 01/2021
1	ChAdOx1 nCoV-19IBA 01/2021
1	Levetiracetam (Keppra)FDA LinkGeneric 01/2021
1	Fluoxetine (Prozac)FDA LinkGeneric 01/2021
1	Voltage-Gated Potassium Channels (Voltage-Gated Potassium Channel)IBA 07/2020
1	Leucine (L-Leucine)FDA Link 07/2020
1	RivaroxabanIBA 01/2020
1	Factor Xa (Coagulation Factor Xa)IBA 01/2020
1	PlasticsIBA 01/2018
1	Biomarkers (Surrogate Marker)IBA 07/2017
1	Liposomes (Liposome)IBA 01/2017
1	Clodronic Acid (Clodronate)IBA 01/2017
1	MuscimolIBA 01/2016
1	14-3-3 Proteins (14-3-3 Protein)IBA 11/2014
1	Fluorescein (Funduscein)FDA LinkGeneric 09/2013

Therapy/Procedure

16	Therapeutics 04/2022 - 02/2002
4	Transplantation 03/2016 - 01/2012
4	Treatment Delay 01/2014 - 10/2006
2	Bone Marrow Transplantation (Transplantation, Bone Marrow) 08/2014 - 01/2008
2	Surgical Casts (Plaster Cast) 02/2014 - 03/2008
2	Drug Therapy (Chemotherapy) 10/2009 - 01/2008
1	Surgical Decompression 01/2022
1	Decompression 01/2022
1	Smart Glasses 01/2021
1	Cupping Therapy 11/2020
1	Cognitive Training 01/2020
1	Time-to-Treatment 01/2020
1	Neurological Rehabilitation 01/2020
1	Thrombectomy 05/2014
1	Physical Therapy Modalities (Physical Therapy Technique) 02/2014